FSC 6505 × ONDANSETRON HYDROCHLORIDE INJECT
ONDANSETRON HYDROCHLORIDE INJECT
6505-01-578-6170 FSC 6505
NSN 6505-01-578-6170 (also written 6505015786170; NIIN 01-578-6170) is an ondansetron hydrochloride inject in Federal Supply Class 6505, Drugs and Biologicals. 7 manufacturer part numbers from 7 suppliers are on record. It was last purchased in Sep 2026.
Open for bid
No open solicitations on record for this NSN right now.
Can you win it?
This item is coded to be bought directly from the actual manufacturer (AMC 3).
AMC 3: buy directly from the actual manufacturer, second or later time. AMSC Z: a commercial, nondevelopmental or off-the-shelf item. The codes describe the item's status on record, not any one solicitation. What the codes mean
What it is — can you make it?
Dimensions, the FLIS specification requirements, and the manufacturer part numbers already qualified against this NSN.
Specifications
From the federal catalog (DLA FLIS / PUB LOG) — what your part has to meet. Cited specification documents can be looked up in ASSIST Quick Search ↗, DoD's public spec repository — copy the document number in.
| Requirement | Value |
|---|---|
| PART NAME ASSIGNED BY CONTROLLING AGENCY CXCY | ONDANSETRON INJECTION USP 2MG/ML 2ML VIAL 25S |
| SPECIAL FEATURES FEAT | ONDANSETRON INJECTION, 2 MG PER ML; 2ML SINGLE DOSE VIALS; PACKAGE OF 25; PROTECT FROM LIGHT; STORE AT USP CONTROLLED ROOM TEMPERATURE |
Manufacturer part numbers
Commercial part numbers cross-referenced to this NSN in the federal catalog — the parts that have been accepted as satisfying this stock number, and who makes them.
| Part number | CAGE | Manufacturer |
|---|---|---|
| 00409000925 | 72QE3 | HOSPIRA WORLDWIDE LLC |
| 14604 | 89875 | DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA |
| 63323037302 | 57KZ6 | FRESENIUS KABI, LLC |
| 6505NCM093985 | 64616 | DEFENSE MEDICAL STANDARDIZATION BOARD |
| NDC00641-6078-25 | 32655 | HIKMA PHARMACEUTICALS USA INC. |
| NDC00703-4755-03 | 86491 | PFIZER INC |
| NDC63323-0373-02 | 1DQP2 | AMERICAN PHARMACEUTICAL PARTNERS |
What it pays — so you can quote
The government's own price and demand record for this NSN — what past awards cleared at, so you know where to land your quote.
Purchase history
No priced purchases on record for this NSN yet.
Related contract actions
Contract action totals, not unit prices — obligation amounts from USAspending for related awards, shown for context only. These do not appear on the price chart above.
| Action date | Award # | Recipient | Agency | Obligation |
|---|---|---|---|---|
| Sep 22, 2026 | SPE2DX25D9900/SPE2DP26F004V ↗ | DMS PHARMACEUTICAL GROUP INC | — | $104.70 |
| Sep 23, 2026 | SPE2DX25D9822/SPE2D226F3560 ↗ | DMS PHARMACEUTICAL GROUP INC | — | $84.00 |
| Sep 24, 2026 | SPE2DX25D9822/SPE2D226F3571 ↗ | DMS PHARMACEUTICAL GROUP INC | — | $10.50 |
| Sep 24, 2026 | SPE2DX25D9900/SPE2DP26F011Y ↗ | DMS PHARMACEUTICAL GROUP INC | — | $10.47 |
| Sep 24, 2026 | SPE2DX25D9900/SPE2DP26F012K ↗ | DMS PHARMACEUTICAL GROUP INC | — | $20.94 |
| Sep 24, 2026 | SPE2DX25D9900/SPE2DP26F012W ↗ | DMS PHARMACEUTICAL GROUP INC | — | $20.94 |
| Sep 25, 2026 | SPE2DX25D9900/SPE2DP26F016A ↗ | DMS PHARMACEUTICAL GROUP INC | — | $20.94 |
| Sep 25, 2026 | SPE2DX25D9900/SPE2DP26F017G ↗ | DMS PHARMACEUTICAL GROUP INC | — | $20.94 |
| Sep 29, 2026 | SPE2DX25D9900/SPE2DP26F025E ↗ | DMS PHARMACEUTICAL GROUP INC | — | $104.70 |
| Sep 29, 2026 | SPE2DX25D9900/SPE2DP26F025U ↗ | DMS PHARMACEUTICAL GROUP INC | — | $52.35 |
| Sep 29, 2026 | SPE2DX25D9900/SPE2DP26F026E ↗ | DMS PHARMACEUTICAL GROUP INC | — | $62.82 |
| Sep 29, 2026 | SPE2DX25D9900/SPE2DP26F026M ↗ | DMS PHARMACEUTICAL GROUP INC | — | $20.94 |
| Sep 29, 2026 | SPE2DX25D9900/SPE2DP26F026Z ↗ | DMS PHARMACEUTICAL GROUP INC | — | $20.94 |
| Sep 29, 2026 | SPE2DX25D9900/SPE2DP26F027G ↗ | DMS PHARMACEUTICAL GROUP INC | — | $31.41 |
| Sep 29, 2026 | SPE2DX25D9900/SPE2DP26F028B ↗ | DMS PHARMACEUTICAL GROUP INC | — | $62.82 |
| Sep 29, 2026 | SPE2DX25D9900/SPE2DP26F028D ↗ | DMS PHARMACEUTICAL GROUP INC | — | $41.88 |
| Sep 29, 2026 | SPE2DX25D9900/SPE2DP26F028V ↗ | DMS PHARMACEUTICAL GROUP INC | — | $31.41 |
| Sep 29, 2026 | SPE2DX25D9822/SPE2D226F3593 ↗ | DMS PHARMACEUTICAL GROUP INC | — | $31.50 |
Demand history
Every solicitation we've indexed for this NSN, open and closed — 1 on record. Closed RFQs (expired, cancelled, or awarded) stay here as a record of past demand; they never get removed.
Who wins this item
Does one supplier win this every time, and are the winners on the listed-source list? One dot per award.
- Award in the last 2 years
- Older award
DMS PHARMACEUTICAL GROUP INC won 10 of the last 10 awards. DMS PHARMACEUTICAL GROUP INC won without being a listed source.
| Solicitation | Issued | Closes / closed | Qty | Status | |
|---|---|---|---|---|---|
| SPE2DP-26-T-4946 | Sep 9, 2026 | Sep 14, 2026 | 1 | Expired | View at DIBBS → |
Open RFQs on DIBBS → DIBBS award history ↗
About this data
- Unit prices: DLA DIBBS award records — every row links to its government record.
- AMSC: latest observed value from DIBBS solicitation history as of Oct 10, 2026.
- Contract action totals: USAspending, context only.
- Data last refreshed: 2026-09-30.
- Full methodology →
Cite this page
NSN Explorer. "ONDANSETRON HYDROCHLORIDE INJECT." nsnexplorer.com, https://nsnexplorer.com/nsn/6505-01-578-6170/. Data as of October 19, 2026.
https://nsnexplorer.com/nsn/6505-01-578-6170/